What's New
News
New AFTD Awareness Ad to Appear in Oct. 20 New York Times
On October 20, the Sunday print edition of the New York Times will feature the latest in…
Target ALS and AFTD Partner to Spur Drug and Biomarker Development for ALS and FTD
Today, AFTD and Target ALS have announced a groundbreaking partnership and call for proposals to identify treatments…
A Care Partner’s Perspective: The Importance of Advocacy
Partners in FTD Care Fall 2019 In her late 40s, Donna, a research chemist/geologist began acting differently….
Preparing to Talk to the Doctor
Partners in FTD Care Fall 2019 Effective pharmacological management of FTD depends on careful, ongoing observation of…
An Overview of Medications Used in FTD
Partners in FTD Care Fall 2019 By Deborah Reed, MD, Guest Contributor Currently there are no FDA-approved…
What to Do About… Medications for FTD Symptoms
Partners in FTD Care Fall 2019 While healthcare providers’ understanding of FTD is increasing, persons diagnosed and…
Only Part of the Answer: Medications and FTD
Partners in FTD Care, Fall 2019 Download the full issue (pdf) Frontotemporal degeneration is clinically and biologically…
“60 Minutes” Brings FTD Awareness to Millions of TV Viewers
On May 5, the venerable CBS news program 60 Minutes aired a segment on FTD, bringing newfound…
More than 600 Take in 2019 AFTD Conference
Held on May 3 in Los Angeles, AFTD’s 2019 Annual Education Conference provided the latest developments in…
AFTD Announces Recipients of 2019-2021 Postdoctoral Fellowships
By supporting talented young investigators during the final stage of their scientific training, AFTD Postdoctoral Fellowships lay…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)